Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission
Go back to Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission| (NASDAQ: INBS) | Delayed: 2.15 -0.08 (3.59%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.23 | 52 Week High | $ | |||
| Open | $2.25 | 52 Week Low | $ | |||
| Day High | $2.29 | P/E | N/A | |||
| Day Low | $2.13 | EPS | $ | |||
| Volume | 69,756 | |||||

